Ipsen announces U.S. FDA submission acceptance of its supplemental New Drug Application for Onivyde…
This section is Partnership Content supplied The content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content.…